Acebrophylline with N-AcetylcysteineASMASAFE N TABLET

Acebrophylline is a sustained-release formulation indicated for the management of chronic respiratory conditions such as bronchial asthma and chronic obstructive pulmonary disease (COPD). It offers dual-action relief through bronchodilation and mucoregulation, making it ideal for patients suffering from productive cough, breathlessness,
and airway inflammation. The sustained-release profile ensures a steady therapeutic effect over 12–24 hours, improving symptom control and patient compliance with once-daily dosing.

• Dosage: Once/Twice Daily OR as directed by the Physician.
• Form: Tablet
• Indications:
  1. Chronic Obstructive Pulmonary Disease (COPD)
  2. Chronic bronchitis
  3. Bronchial asthma
  4. Bronchiectasis
  5. Pulmonary fibrosis
  6. Respiratory infections with thick, tenacious sputum
• Composition: Acebrophylline 100 mg + N-Acetylcysteine 600 mg
• Mode of Action: NAC breaks mucus bonds and restores glutathione, reducing viscosity and oxidative stress. Acebrophylline relaxes airways, enhances clearance, and reduces inflammation.
  Together, they offer synergistic mucolytic, antioxidant, and bronchodilatory action for improved lung function in chronic respiratory diseases.
• Packaging:10*1*15’s
• Therapy Area: Respiratory Medicine